Laboratory research paves the way for a clinical trial to see if an FDA-approved drug used to prevent organ transplant rejection can work against these aggressive brain tumors.

Funding from the Taubman Institute has helped a team of researchers develop a new approach to treating aggressive brain tumors. Daniel Wahl, MD, PhD, a radiation oncologist and researcher at Michigan Medicine, says an existing drug used to prevent organ transplant rejection may make radiation therapy more effective for glioblastoma patients by targeting a critical…

Taubman Scholar Named Chair, Dept. of Pediatrics

The Taubman Institute congratulates Donna M. Martin, MD, PhD, who was appointed chair of the Department of Pediatrics. She also became the Ravitz Foundation Endowed Professor of Pediatrics and Communicable Diseases. Dr. Martin is the Donita B. Sullivan, M.D., Research Professor of Pediatrics and Communicable Diseases, and a professor of pediatrics and human genetics in…

Taubman Emerging Scholar Sheds Light on Possible Suicide Risk of Covid-19 Front Line Caretakers

Srijan Sen, MD, PhD, Associate Professor, Psychiatry, Associate Vice President for Health Sciences, and Frances and Kenneth Eisenberg Professor of Depression and Neurosciences, is one of five mental health care providers and advocates who discuss elevated suicide risk in the most recent issue of BridgeMI.com. In the article, Dr. Sen says, “There is this issue…